Is Mounjaro Available on the NHS in Wales?

Step 1: Understand how NICE decisions reach Welsh patients

NICE technology appraisals (like TA1026, which recommended tirzepatide for weight management in December 2024) are technically binding in England. In Wales, NHS recommendations are issued separately by the All Wales Medicines Strategy Group (AWMSG). AWMSG considers NICE appraisals and may accept, adapt or defer them. Until AWMSG publishes a positive recommendation and NHS Wales issues commissioning guidance, Welsh health boards are not obliged to fund Mounjaro for weight management, and most currently do not.

This is not unusual. There has historically been a gap of months to over a year between NICE approval and confirmed Welsh commissioning for specialist medicines. NHS England's phased rollout began from June 2025 and is expanding in cohort steps; Wales is running its own separate process. If you want to understand whether Mounjaro is available on the NHS and track the latest position, that page covers England's rollout in detail alongside the devolved picture.

For anyone specifically trying to follow how Mounjaro is progressing through NHS Wales commissioning, that page sets out where the AWMSG process currently stands and what to watch for. For now, the practical reality for most people in Wales is straightforward: NHS access is not yet a reliable route. That may change, but waiting for it to arrive is a choice, not the only option.

Step 2: Know what the private prescription route actually looks like

A private prescription follows the same clinical logic as an NHS one, a prescriber reviews your health picture, confirms you meet the licensed criteria, and issues the prescription. The licensed eligibility for Mounjaro covers adults with a BMI of 30 or above, or 27 and above if you have at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not guarantee approval; the prescriber weighs the whole picture.

At nume, that review is done by a GPhC-registered Independent Prescriber, a real clinician reading your consultation, not automated software working through a checklist. Once approved, orders placed by 12pm on weekdays are dispatched the same day; a DPD tracking notification arrives on your phone and the pen itself comes the next working day in a plain, unmarked box. For anyone in Wales currently navigating long NHS waiting lists or uncertain local commissioning timelines, that is the alternative worth understanding.

You can read more about the private prescription process on our Mounjaro private prescription page. If you are wondering whether you can buy Mounjaro from a chemist without going through an online provider, that page also explains what the dispensing process looks like in practice.

Step 3: Weigh up the cost honestly

Private Mounjaro is not free, and it is fair to say that upfront. Since Eli Lilly revised UK list prices in September 2025, the cost of tirzepatide pens varies considerably by dose and provider, typically somewhere in the range of £149 to £375 per month across the market, as widely reported. Our Mounjaro cost page breaks down what those figures include and what they often hide.

At nume, the price you see covers the consultation, the prescription, the medicine and free next-working-day delivery. There are no separate consultation fees, no subscription, and no auto-renewal. A prescriber reviews every repeat order afresh. We are not the cheapest option in the market, and that is deliberate. The question worth asking is not which provider quotes the lowest number, but whether the supply chain is verified, the prescriber is real, and the aftercare is there when you need it. The MHRA has warned publicly about counterfeit weight-loss pens seized in the UK, including a raided manufacturing site producing fake tirzepatide. For a prescription medicine, price is the wrong test.

Step 4: Check whether you're ready to start

If you're in Wales and considering private treatment now rather than waiting for NHS commissioning to catch up, the next step is a clinical consultation. Our clinical team reviews every consultation the same day it's submitted. You'll need to confirm your ID and weight on a short video call, that's standard practice at a pharmacy operating to GPhC standards, and it protects you. You can verify our pharmacy registration at any time on the GPhC register (premises number 9012878).

If you'd prefer to read more about treatment options before committing to anything, our weight-loss treatments overview covers both Mounjaro and Wegovy alongside the factors that typically guide a prescriber's recommendation. There is no pressure and no auto-enrolment. When you're ready, check your eligibility with a free consultation.